May 1, 2012 (New Orleans, Louisiana) — A transdermal patch that delivers 8 mg of the dopamine-receptor agonist rotigotine (Neupro, UCB) in a once-daily, single application is the lowest effective dose ...
June 17, 2004 (Rome) — The transdermally delivered dopamine agonist rotigotine is effective and well tolerated in patients with early idiopathic Parkinson’s disease, according to a team of researchers ...
VANCOUVER, BC / ACCESSWIRE / February 13, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT) is pleased to report an update on its commercialization plan for its ...
VANCOUVER, BC / ACCESSWIRE / May 15, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has received government approval for to ...
Shilpa Medicare Limited ( (IN:SHILPAMED)) has provided an announcement. Shilpa Medicare Limited has received initial authorization from Europe for its Rotigotine transdermal patch, a generic version ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results